Bank of America’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,423
| Closed | -$13.8K | – | 8417 |
|
|
2025
Q1 | $13.8K | Sell |
3,423
-86,618
| -96% | -$289K | ﹤0.01% | 7048 |
|
|
2024
Q4 | $288K | Buy |
90,041
+89,744
| +30,217% | +$304K | ﹤0.01% | 5917 |
|
|
2024
Q3 | $665 | Buy |
297
+25
| +9% | +$58 | ﹤0.01% | 7324 |
|
|
2024
Q2 | $585 | Buy |
+272
| New | +$484 | ﹤0.01% | 7328 |
|
|
2024
Q1 | – | Sell |
-25
| Closed | -$57 | – | 7782 |
|
|
2023
Q4 | $57 | Buy |
25
+24
| +2,400% | +$52 | ﹤0.01% | 7479 |
|
|
2023
Q3 | $2 | Hold |
1
| – | – | ﹤0.01% | 7710 |
|
|
2023
Q2 | $2 | Sell |
1
-3,241
| -100% | -$8.85K | ﹤0.01% | 7638 |
|
|
2023
Q1 | $7.29K | Sell |
3,242
-199,218
| -98% | -$1,000K | ﹤0.01% | 6990 |
|
|
2022
Q4 | $1.03M | Buy |
202,460
+201,460
| +20,146% | +$1.45M | ﹤0.01% | 4822 |
|
|
2022
Q3 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 7227 |
|
|
2022
Q2 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 7382 |
|
|
2022
Q1 | $18K | Sell |
1,000
-22,110
| -96% | -$475K | ﹤0.01% | 7553 |
|
|
2021
Q4 | $719K | Buy |
23,110
+20,583
| +815% | +$682K | ﹤0.01% | 5572 |
|
|
2021
Q3 | $83K | Sell |
2,527
-3,507
| -58% | -$104K | ﹤0.01% | 6819 |
|
|
2021
Q2 | $178K | Buy |
6,034
+1,904
| +46% | +$52.8K | ﹤0.01% | 6168 |
|
|
2021
Q1 | $130K | Buy |
4,130
+2,077
| +101% | +$69.6K | ﹤0.01% | 6281 |
|
|
2020
Q4 | $54K | Buy |
2,053
+1,635
| +391% | +$41.4K | ﹤0.01% | 6290 |
|
|
2020
Q3 | $11K | Sell |
418
-134
| -24% | -$3.22K | ﹤0.01% | 6427 |
|
|
2020
Q2 | $11K | Sell |
552
-9,549
| -95% | -$174K | ﹤0.01% | 6415 |
|
|
2020
Q1 | $153K | Sell |
10,101
-203
| -2% | -$3.59K | ﹤0.01% | 5260 |
|
|
2019
Q4 | $177K | Buy |
10,304
+9,851
| +2,175% | +$165K | ﹤0.01% | 5701 |
|
|
2019
Q3 | $12K | Sell |
453
-5
| -1% | -$137 | ﹤0.01% | 6681 |
|
|
2019
Q2 | $14K | Buy |
458
+367
| +403% | +$14.4K | ﹤0.01% | 6648 |
|
|
2019
Q1 | $3K | Buy |
+91
| New | +$2.9K | ﹤0.01% | 6853 |
|
|
2018
Q2 | – | Sell |
-206
| Closed | -$9K | – | 7098 |
|
|
2018
Q1 | $9K | Buy |
+206
| New | +$8.95K | ﹤0.01% | 6630 |
|
Bank of America's CKPT Position: Q2 2025 in Review
Bank of America sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 3,423 shares — an estimated $13.8K sold.
Bank of America first reported a position in CKPT in Q1 2018 and held it in 25 quarters. The position peaked at $1.03M in Q4 2022. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.
- Bank of America reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
- Bank of America sold 3,423 Checkpoint Therapeutics shares in Q2 2025, an estimated $13.8K.
- Bank of America first reported a position in Checkpoint Therapeutics in Q1 2018 and held it in 25 quarters.
- Bank of America's Checkpoint Therapeutics position peaked at $1.03M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.
Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.